The Cleft Palate-Craniofacial JournalGenetic & Genomic MedicinePeer-reviewed journal article
DNA methylation effects on Van der Woude Syndrome phenotypic variability
Amanda Seaberg, Waheed A. AwotoyeiD, Fang QianiD, Ligiane Alves Machado‐PaulaiD, Lindsey DunlayiD, Azeez ButaliiD, Jeffrey C. MurrayiD, Lina M. Moreno‐UribeiD, Aline Lourenço PetriniD
Abstract
OBJECTIVEVan der Woude Syndrome (VWS) classically presents with combinations of lip pits (LP) and orofacial clefts, with marked phenotypic discordance even amongst individuals carrying the same mutation. Such discordance suggests a possible role for epigenetic factors as phenotypic modifiers. Both IRF6, causal for 70% of VWS cases, and TP63 interact in a regulatory loop to coordinate epithelial proliferation and differentiation for palatogenesis. We hypothesize that differential DNA methylation (DNAm) in CpG sites within regulatory regions of IRF6 and TP63 are associated with VWS phenotypic discordance. METHODSWe measured DNAm levels of CpG sites located in the promoter regions of IRF6 and TP63 and in an IRF6 enhancer element (MCS9.7) in 83 individuals with VWS grouped within 5 phenotypes for primary analysis: 1=CL+/-P+LP, 2=CL+/-P, 3=CP+LP, 4=CP, 5=LP and 2 phenotypes for secondary analysis: 1=any cleft and LP, 2= any cleft without LP. DNA samples were bisulfite converted and pyrosequenced with target-specific primers. Methylation levels were compared amongst phenotypes. RESULTSCpG sites in the IRF6 promoter showed statistically significant differences in methylation among phenotypic groups in both analyses (P<0.05). Individuals with any form of cleft (Groups 1-4) had significantly higher methylation levels than individuals with lip pits only (Group 5). In the secondary analysis, individuals in Group 1 (cleft+LP) had significantly higher methylation than Group 2 (cleft only). CONCLUSIONResults indicated that hypermethylation of the IRF6 promoter is associated with more severe phenotypes (any cleft +/- lip pits); thus, possibly impacting an already genetically weakened IRF6 protein and leading to a more severe phenotype.
- organism: human
- assay: DNA methylation
- research focus: differential expression
- approach: statistical model
- Citations
- 6
- FWCI
- 1.59
- Field percentile
- top 18%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rare variants in PRKCI cause Van der Woude syndrome and other features of peridermopathy
Kelsey R. Robinson, Sunil Kumar Singh, … Elizabeth J. Leslie·The American Journal of Human GeneticsPeer-reviewed·Sep 2, 2025
- DNA methylation mediates genetic liability to non-syndromic cleft lip/palate
Laurence J Howe, Tom G. Richardson, … Gemma C. Sharp·EpigenomicsPeer-reviewed·Jan 14, 2019
- DNA methylation signature in NSD2 loss-of-function variants appeared similar to that in Wolf-Hirschhorn syndrome
Tomoko Kawai, Shiori Kinoshita, … Kenichiro Hata·bioRxiv·Jan 6, 2023
- Epigenomic signature of major congenital heart defects in newborns with Down syndrome
Julia S. Mouat, Shaobo Li, … Janine M. LaSalle·Human GenomicsPeer-reviewed·Oct 6, 2023
- Comparative Genome-Wide DNA Methylation Analysis In Myocardial Tissue From Donors With And Without Down Syndrome
Romina Beatriz Cejas, Jie Wang, … Javier G. Blanco·GenePeer-reviewed·Aug 27, 2020
- Identification of SENP7 and UTF1/VENTX as new loci influencing clusteredprotocadherin methylation across blood and brain using a genome-wide associationstudy
Yunfeng Liu, Maja Vukić, … Bastiaan T. Heijmans·Molecular PsychiatryPeer-reviewed·Oct 2, 2025